Results 201 to 210 of about 35,753 (257)

Application of bis-eugenol to a zinc oxide eugenol cement

Journal of Dentistry, 1999
To assess the usefulness of dimerized eugenol (bis-eugenol) in dentistry, the physical properties of zinc oxide eugenol cement (ZOE) with bis-eugenol and the cytotoxicity of bis-eugenol were studied.Setting time, compressive strength, solubility and disintegration of ZOE cement with bis-eugenol according to the specifications of JDMAS315 were evaluated.
Takao Ueha, Y Hibino
exaly   +3 more sources

A Comparison of the Inflammatory Response Produced by Commercial Eugenol and Purified Eugenol

open access: yesJournal of Dental Research, 1981
Eugenol is one of the major therapeutic agents in dentistry. The inflammatory responses to purified and commercial eugenol are compared, and the inflammatory responses to zinc oxide/eugenol prepared with either purified or commercial eugenol are also compared.
J G, Webb, N E, Bussell
openaire   +3 more sources

ANTIANAPHYLACTIC PROPERTIES OF EUGENOL

Pharmacological Research, 1997
The effects of eugenol, a major component of clove, on anaphylaxis were evaluated in rats. Eugenol inhibited compound 48/80-induced systemic anaphylaxis 100% with a dose of 10 micrograms g-1 body weight (BW). While serum levels of histamine were markedly elevated after compound 48/80 injection in all groups of rats, rats injected with eugenol showed a ...
Hyung Min Kim, T Y Shin
exaly   +3 more sources

Eugenol release and the cytotoxicity of different zinc oxide-eugenol combinations

Journal of Dentistry, 1988
The relationship between the toxicity and release of eugenol from different zinc oxideeugenol (ZOE) combinations was examined in this study in vitro using the model cavity method. Both eugenol release and toxicity were higher from conventional ZOE mixtures than from mixtures using a reinforced zinc oxide powder.
S D Meryon, S D Meryon
exaly   +3 more sources

Antiplatelet and calcium inhibitory properties of eugenol and sodium eugenol acetate

General Pharmacology, 1996
1. Eugenol (3-methoxy-4-hydroxy-propenylbenzene) or sodium eugenol acetate (4-O-acetic acid sodium-3-methoxy-1-propenylbenzene) (0.25, 0.5, 1 mM) concentration-dependently inhibited arachidonic acid (AA)-, collagen-, epinephrine- and ADP-induced platelet aggregation. 2.
Ing-Jun Chen, I J Chen
exaly   +3 more sources

Effect of eugenol and eugenol cements on cured composite resin

The Journal of Prosthetic Dentistry, 1983
Although the chemical nature of the reaction of eugenol and composite resin is not understood, this preliminary investigation indicates that eugenol and eugenol-containing cements alter the surface of cured composite resins.
P L, Millstein, D, Nathanson
openaire   +2 more sources

The metabolism of eugenol in man

Xenobiotica, 1990
1. The metabolism of eugenol (4-hydroxy-3-methoxy-allylbenzene) was investigated in male and female healthy volunteers. It was rapidly absorbed and metabolized after oral administration and was almost completely excreted in the urine within 24 h. Unmetabolized eugenol excreted in urine amounted to less than 0.1% of the dose. 2.
I U, Fischer   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy